Back to Search Start Over

Efficient synthesis and evaluation of therapeutic potential of fluorine containing 2-arylchromen-4-ones.

Authors :
Troshkova N
Politanskaya L
Wang J
Niukalova M
Khasanov S
Esaulkova I
Zarubaev V
Boltneva N
Rudakova E
Kovaleva N
Serebryakova O
Makhaeva G
Valuisky N
Ibragimova U
Litvinov R
Babkov D
Usenov K
Chertenkov M
Pokrovsky M
Cheresiz S
Pokrovsky A
Source :
Molecular diversity [Mol Divers] 2024 Jul 16. Date of Electronic Publication: 2024 Jul 16.
Publication Year :
2024
Publisher :
Ahead of Print

Abstract

A large series of 2-arylchromen-4-ones containing from 1 to 3 fluorine atoms or a trifluoromethyl group in the structure was synthesized by condensation of fluorinated 2-hydroxyacetophenones with benzaldehydes in an alkaline medium and subsequent oxidative cyclization of the resulting 2'-hydroxychalcones by action of I <subscript>2</subscript> in DMSO. The cytotoxicity of the obtained compounds was studied in glioblastoma cell line, SNB19, and in a monkey-derived normal kidney epithelium cell line, Vero. In addition, antiglycation activity of the obtained compounds was evaluated. The inhibitory activity of some fluorinated 2-arylchromen-4-ones against acetylcholinesterase, butyrylcholinesterase and carboxylesterase as well their primary antioxidant activity in ABTS and FRAP tests were investigated. Screening of the synthesized compounds for their inhibitory activity against influenza A virus A/Puerto Rico/8/34 (H1N1) in the MDCK cell culture revealed that fluorinated compounds 32, 31 and 39 showed manifest antiviral effects (with IS = 57, 38 and 25 correspondingly) that makes this series of new biologically attractive fluorinated heterocycles promising for further development and in-depth study.<br /> (© 2024. The Author(s), under exclusive licence to Springer Nature Switzerland AG.)

Details

Language :
English
ISSN :
1573-501X
Database :
MEDLINE
Journal :
Molecular diversity
Publication Type :
Academic Journal
Accession number :
39012566
Full Text :
https://doi.org/10.1007/s11030-024-10925-6